CANRISK — Canadian Diabetes Risk Questionnaire
8-item validated questionnaire for screening pre-diabetes and undiagnosed type 2 diabetes in Canadian adults ≥40 years. Score ≥21 = high risk. Similar to FINDRISC/AUSDRISK but adapted for Canadian population including Aboriginal and South Asian groups.
Score interpretation
CANRISK <21 — low risk of pre-diabetes or undiagnosed type 2 diabetes
→ Lifestyle education; reassess every 3 years; if any single risk factor is present, consider fasting glucose every 1–3 years
CANRISK ≥21 — high risk of pre-diabetes or undiagnosed T2DM
→ Fasting plasma glucose and HbA1c; if pre-diabetic: structured diabetes prevention programme; if diagnosed T2DM: initiate treatment (metformin + lifestyle); annual biochemical review; address CVD risk factors; refer to diabetes educator and dietitian
Interpretation bands for the CANRISK. Apply clinical judgement and local guidance.
References
- Gao M et al. Validation of the CANRISK questionnaire to screen for prediabetes and undiagnosed type 2 diabetes in Canadian adults. Chronic Dis Inj Can. 2010;30(4):132–140.
Related
Curated clinical cross-links plus same-class fallbacks.
- Tirzepatide · Dual GIP/GLP-1 Receptor Agonist — Type 2 Diabetes / Obesity
- Botulinum Toxin Type A (ENT) · Neuromuscular Blocking Agent (Botulinum Toxin)
- Tuberculin purified protein derivative · Mycobacterial antigen for delayed-type hypersensitivity testing
- Ethosuximide · Antiepileptic — T-type Calcium Channel Blocker
- Botulinum toxin type A · Neuromuscular blocker (presynaptic)
- Metformin (Gestational Diabetes / PCOS) · Biguanide — Gestational Diabetes / PCOS
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.